CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
EKG Patch monitors (Zio and Carnation)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02952781
NCT02952781N/ACompleted
CompareCT.gov

Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial

EvergreenHealth·observational·Posted Nov 2, 2016·Updated Mar 7, 2017

In Brief

An observational study evaluating EKG Patch monitors (Zio and Carnation) for Syncope and 3 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The purpose of this research is to test the clinical value of a new P-wave sensitive recording vector compared to a standard ECG limb lead II vector from similar easy-to-use long-term cardiac rhythm monitoring patch systems, the Carnation TM Ambulatory Monitoring (CAM) System and the Zio-XT iRhythm. The P-wave is a critical aspect of the electrocardiogram. The purpose of this study is to see if the P-wave centric focus of the CAM system improves arrhythmia diagnosis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSyncope, Presyncope, Atrial Fibrillation, Supraventricular Tachycardia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 2, 2016
Enrollment StartOct 1, 2016
Primary CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.7 years ago

Interventions

EKG Patch monitors (Zio and Carnation)device

Each patient will be provided with both a Zio-XT Patch monitoring system and the CAM system and will be instructed to wear both simultaneously for 7 days.